Chiadi Onyike

Associate Professor

Johns Hopkins University School of Medicine
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Objective Spinocerebellar ataxia type 3 (SCA3) is a rare, inherited neurodegenerative disease. Here, we profile the spatial spread of atrophy across the whole brain, determine whether brain degeneration preferentially maps onto specific functional networks, and investigate the relationship between cerebellar and cerebral anatomical changes. Methods Whole-brain grey and white matter (GM and WM) voxel-based morphometry was performed on 408 individuals with SCA3 (82 pre-ataxic) and 293 controls. The SCA3 cohort was stratified by ataxia severity to investigate disease progression, with cerebellar GM atrophy mapped onto a task-based functional atlas. Volume was correlated with disease duration and intensity. Cerebrocerebellar volumetric covariance was assessed to determine whether atrophy was coupled between infra- and supratentorial regions. Results The pattern of atrophy is spatially consistent but progressive in magnitude across the disease course. The greatest atrophy was found in the pons, cerebellar WM, and cerebellar peduncles; correlations with disease severity and duration were also strongest in these regions. Cerebellar GM atrophy was greatest in functional regions associated with motor execution and planning, attention, and emotional processing. Sparse cerebral cortical atrophy appears only in the most severe disease subgroup, while striatal atrophy begins in the earliest stages. Reduced cerebrocerebellar structural covariance is observed in SCA3 participants versus controls. Interpretation While cerebellar and brainstem atrophy become more severe, the pattern of atrophy remains largely consistent as SCA3 progresses. Cerebellar GM degeneration occurs in regions associated with motor, cognitive, and affective control, in line with clinical presentation. Cerebellar atrophy is not directly mirrored by cerebral changes.

Year:

2025

Objectives Hyperorality is one of the core features of behavioral variant frontotemporal dementia (bvFTD), however, the cognitive, psychiatric, and neuroanatomic correlates of hyperorality across disease stages remain unclear. This study works to fill this knowledge gap by exploring these associations in the early and advanced stages of bvFTD. Methods Participants with sporadic and genetic bvFTD were enrolled in the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration consortium (ALLFTD). The primary analyses used baseline data to compare cognitive and psychiatric symptoms in those with and without hyperorality stratified by disease severity. Linear multivariable regressions adjusting for age and total intracranial volume were used to examine baseline associations between regional gray matter volumes and hyperorality status. Five anatomic regions of interest were pre-selected for analysis based on previously identified neuroanatomic correlates of hyperorality in bvFTD. Results Hyperorality was present in 50% of early-stage bvFTD participants (n = 136) and was associated with higher rates of ritualistic/compulsive behavior. Hyperorality was present in 63% of advanced-stage participants (n = 208) and was associated higher rates of apathy, and ritualistic/compulsive behavior. Regional gray matter volumes were similar in those with and without hyperorality in early-stage participants. In the advanced-stage participants, hyperorality was associated with lower gray matter volumes in the right dorsal and ventral striatum. Conclusions Hyperorality emerges early in bvFTD and is accompanied by deficits in social cognition and complex-ritualistic behavior prior to clinically significant gray matter volume loss. These findings suggest that early identification and treatment of hyperorality could improve neuropsychiatric trajectories in bvFTD.

Year:

2024

Introduction Dementia prevalence is rising in sub-Saharan Africa due to a combination of factors, including population growth and aging. In resource-constrained settings, such as Northeastern Nigeria, dementia management is challenged by delayed diagnosis and limited specialist care. This study evaluates the burden of dementia and its management at the Federal Neuropsychiatric Hospital Maiduguri (FNHM), the only neuropsychiatric facility in Northeastern Nigeria. The study aims to provide insights into current dementia trends and practices and identify key areas for improvement. Methods A retrospective analysis of patient records at FNPH Maiduguri was conducted, including patients aged 60 and above diagnosed with dementia between 1999 and 2023. Data on patient demographics, dementia subtypes, comorbidities, symptoms, diagnostic investigations, and treatment modalities were analysed. Results The Available record from the hospital health records register showed that the total number of diagnosed cases of dementia in the FNHM is 1,216 cases with a male predominance (56%). Alzheimer’s disease was the most common subtype (60.5%), followed by vascular dementia (24.5%). Hypertension was the most frequently reported comorbidity (41.6%). Cognitive symptoms, particularly memory loss, were reported in all cases, while behavioural symptoms, such as agitation and hallucinations, were reported in some cases. The most commonly administered treatments included cognitive enhancers (donepezil), supplements (gingko biloba), and non-drug therapies (psychoeducation). However, 70.9% of patients were lost to follow-up, highlighting a critical gap in long-term care. Conclusion The increasing burden of dementia at the only neuropsychiatric facility in Northeastern Nigeria highlights the urgent need for investments and targeted interventions. Enhancing patient engagement, strengthening follow-up systems, and expanding diagnostic and treatment capacities will improve care outcomes and address the growing demands for dementia management in this underserved region.

Year:

2024

Frontotemporal lobar degeneration with neuronal inclusions of the TAR DNA-binding protein 43 (FTLD-TDP) is a fatal neurodegenerative disorder with only a limited number of risk loci identified. We report our comprehensive genome-wide association study as part of the International FTLD-TDP Whole-Genome Sequencing Consortium, including 985 cases and 3,153 controls, and meta-analysis with the Dementia-seq cohort, compiled from 26 institutions/brain banks in the United States, Europe and Australia. We confirm UNC13A as the strongest overall FTLD-TDP risk factor and identify TNIP1 as a novel FTLD-TDP risk factor. In subgroup analyses, we further identify for the first time genome-wide significant loci specific to each of the three main FTLD-TDP pathological subtypes (A, B and C), as well as enrichment of risk loci in distinct tissues, brain regions, and neuronal subtypes, suggesting distinct disease aetiologies in each of the subtypes. Rare variant analysis confirmed TBK1 and identified VIPR1 , RBPJL , and L3MBTL1 as novel subtype specific FTLD-TDP risk genes, further highlighting the role of innate and adaptive immunity and notch signalling pathway in FTLD-TDP, with potential diagnostic and novel therapeutic implications.

Year:

2024

Collaborators (35)

Benjamin Bender

University Hospital

GERMANY
View details

Giulia Coarelli

Institut du Cerveau et de la Moelle Épinière

FRANCE
View details

Edward B Lee

PI

University of Pennsylvania Perelman School of Medicine

UNITED STATES
View details

Ian H. Harding

Group Leader

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Harro Seelaar

Neurologist

Erasmus MC

NETHERLANDS
View details

Brittany Dugger

Associate Professor

University of California, Davis

UNITED STATES
View details

Lawrence Honig

Professor, Director of NYS Center of Excellence for Alzheimer's Disease, Deputy Director Alzheimer's Disease Research Center

Columbia University Irving Medical Center

UNITED STATES
View details

Thiago Rezende

Associate Researcher

University of Campinas

BRAZIL
View details

Andreas Deistung

University Hospital Halle (Saale)

GERMANY
View details

Ging-Yuek Hsiung

The University of British Columbia

CANADA
View details

Alexander Pantelyat

Associate Professor

Johns Hopkins University

UNITED STATES
View details

Caroline Graff

Professor,MD PhD

Karolinska Institutet

SWEDEN
View details

Kathrin Reetz

Full Professor for Translational Neurodegeneration

-

GERMANY
View details

Jennifer Yokoyama

University of California

UNITED STATES
View details

Fernando Cendes

Full Professor

University of Campinas

BRAZIL
View details

Christopher Morrow

Johns Hopkins University School of Medicine

UNITED STATES
View details

Nupur Ghoshal

Professor

Washington University in St. Louis

UNITED STATES
View details

Matthis Synofzik

Professor

Hertie Institute for clinical brain research

GERMANY
View details

Melissa Murray

Professor

Mayo Clinic Research Florida

UNITED STATES
View details

Olivier Piguet

University of Sydney

AUSTRALIA
View details

Charles White

Professor

-

UNITED STATES
View details

Alexandra Durr

Professor, MD, PhD

Sorbonne Université

FRANCE
View details

Andreia Faria

earth and planetary sciences johns hopkins university baltimore maryland usa

UNITED STATES
View details

Bart van de Warrenburg

Associate professor, neurologist, principal investigator

Radboud Universitair Medisch Centrum

NETHERLANDS
View details

Irene Litvan

Professor

University of California, San Diego

UNITED STATES
View details

David Arpin

University of Florida

UNITED STATES
View details

Carlos Cruchaga

Professor

Washington University in St. Louis

UNITED STATES
View details

Neill Graff-Radford

Professor

Mayo Clinic Florida

UNITED STATES
View details

Dennis W Dickson

Professor

Mayo Clinic Florida

UNITED STATES
View details

Dagmar Timmann

University Hospital Essen

GERMANY
View details

Jennifer Faber

Head of Ataxia Clinic

University Hospital Bonn

GERMANY
View details

Marcondes França Junior

Assistant professor

University of Campinas

BRAZIL
View details

Jerry L. Prince

William B Kouwenhoven Professor

Johns Hopkins University

UNITED STATES
View details

Gulin Oz

Faculty, Professor

University of Minnesota

UNITED STATES
View details

Henry Paulson

University of Michigan

UNITED STATES
View details